Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 6, 2013Isoniazid Tablets 300 mg tablets USPFailed Dissolution Specifications; 36 month stability timepointWest-ward Pharmaceutical Corp. · D-174-2013Class IITerminatedMar 6, 2013Dextroamphetamine Sulfate Extended Release CapsulesFailed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.Amedra Pharmaceuticals LLC · D-173-2013Class IITerminatedMar 6, 2013Dextroamphetamine Sulfate Extended Release CapsulesFailed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.Amedra Pharmaceuticals LLC · D-172-2013Class IITerminatedMar 6, 2013Dextroamphetamine Sulfate Extended Release CapsulesFailed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.Amedra Pharmaceuticals LLC · D-171-2013Class IITerminatedMar 6, 2013Belladonna AlkaloidsPresence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.West-ward Pharmaceutical Corp. · D-170-2013Class IITerminatedMar 6, 2013Furosemide Injection USPLack of Assurance of Sterility; possible loose crimp applied to fliptop vialHospira, Inc. · D-169-2013Class IITerminatedMar 6, 2013EXPARELSubpotent; bupivacainePacira Pharmaceuticals, Inc. · D-168-2013Class IIITerminatedFeb 27, 2013Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral RinseCross Contamination with Other Products: Product was mixed with another type of mouth wash.Procter & Gamble Hair Care Llc · D-167-2013Class ITerminatedFeb 27, 2013Hydrocodone Bitartrate and Acetaminophen TabletsSuperpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-166-2013Class ITerminatedFeb 27, 2013SLIMDIA Revolution capsulesMarketed Without an Approved NDA/ANDA: All lots of the dietary supplement Slimdia Revolution are being recalled because they contain sibutramine, a previously approved...P & J Trading Co · D-165-2013Class IIITerminatedFeb 20, 2013Glycopyrrolate TabletsSubpotent DrugWest-ward Pharmaceutical Corp. · D-164-2013Class IIITerminatedFeb 20, 2013Lac-HydrinCrystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.Ranbaxy Inc. · D-163-2013Class IIITerminatedFeb 20, 2013Lac-HydrinCrystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.Ranbaxy Inc. · D-162-2013Class IITerminatedFeb 20, 201312-Hour SinusMicrobial Contamination of a Non-Sterile Products: 12-Hour Sinus Nasal Spray under various labeling are being recalled due to microbial contamination identified during...Lee Pharmaceuticals, Inc · D-161-2013Class IITerminatedFeb 20, 2013Propranolol Hydrochloride Extended-release CapsulesFailed Dissolution Test RequirementsUpsher Smith Laboratories, Inc. · D-160-2013Class IITerminatedFeb 20, 2013Propofol Injectable EmulsionPresence of Particulate Matter: Visible particulate and particulate embedded in vials were observed during retain inspection.Hospira Inc. · D-159-2013Class ITerminatedFeb 13, 2013Isovue -300Presence of Particulate Matter; fibers identified as cellulose and polyvinylBracco Diagnostic Inc · D-158-2013Class ITerminatedFeb 13, 2013Isovue -370Presence of Particulate Matter; fibers identified as cellulose and polyvinylBracco Diagnostic Inc · D-157-2013Class IIITerminatedFeb 13, 2013Leukine sargramostim 5 x 500 mcg/mL vialImpurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.Bayer HealthCare Pharmaceuticals Inc. · D-156-2013Class ITerminatedFeb 13, 2013Zicam Extreme Congestion ReliefMicrobial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.Matrixx Initiatives Inc · D-155-2013Class ITerminatedFeb 13, 2013Carboplatin InjectionCrystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as...Hospira Inc. · D-154-2013Class ITerminatedFeb 13, 2013Carboplatin InjectionCrystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as...Hospira Inc. · D-153-2013Class IIITerminatedFeb 13, 2013Syeda (drospirenone and ethinyl estradiol)Tablet/Capsule Imprinted with Wrong ID; a portion of the tablets could contain the incorrect debossing on one side of the tablet U2 instead of U3.Sandoz Incorporated · D-152-2013Class IIITerminatedFeb 13, 2013ESTEE LAUDER DayWear Sheer Tint ReleaseFailed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than...Estee Lauder Inc · D-151-2013Class IITerminatedFeb 13, 2013Carisoprodol TabletsPresence of Foreign Substance: Uncharacteristic blacks spots on tablets.West-ward Pharmaceutical Corp. · D-150-2013Class IITerminatedFeb 13, 2013PredniSONE TabletsPresence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.West-ward Pharmaceutical Corp. · D-149-2013Class ITerminatedFeb 13, 2013SLIM XTREME Herbal Slimming CapsuleMarketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for...Globe All Wellness, LLC · D-148-2013Class IITerminatedFeb 13, 2013Lansoprazole Delayed-release CapsulesPresence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.Mylan Pharmaceuticals Inc. · D-147-2013Class IIITerminatedFeb 13, 2013EstroGelDefective Container: Pump head detaching from the canister unit upon removal of the overcap.Ascend Therapeutics Inc · D-146-2013Class IITerminatedFeb 13, 2013Taztia XTFailed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41%...Watson Pharmaceuticals · D-145-2013Class IIITerminatedFeb 13, 2013Methocarbamol 750 mg TabletsLabeling: Incorrect or missing lot and/or expiration date. The product was mistakenly labeled with an expiration date of 10/16 instead of 01/16.Stat Rx USA · D-144-2013Class IIITerminatedFeb 13, 2013VentavisSubpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.Actelion Pharmaceuticals U.S., Inc. · D-143-2013Class IIITerminatedFeb 6, 2013Femtrace 0.45 mgFailed Impurity/Degradation Specifications due to moisture ingress in individual bottlesWarner Chilcott Company LLC · D-142-2013Class IIITerminatedFeb 6, 2013Femtrace 0.9 mgFailed Impurity/Degradation Specifications due to moisture ingress in individual bottlesWarner Chilcott Company LLC · D-141-12013Class IITerminatedFeb 6, 2013HILLYARDMicrobial Contamination of Non-Sterile Products: The product may be contaminated with bacteria.Hillyard GMP · D-140-2013Class IITerminatedFeb 6, 2013TemodarFailed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during...Schering-Plough Products, LLC · D-139-2013Class ITerminatedFeb 6, 2013Hydrocodone bitartrate and acetaminophen TabletsSuperpotent (Multiple Ingredient) Drug: Complaint received of oversized tablets.Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals · D-138-2013Class IITerminatedFeb 6, 2013Carvedilol TabletsFailed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.Mylan Pharmaceuticals Inc. · D-137-2013Class IIITerminatedJan 30, 2013Flanax (aluminum hydroxideDefective Container: Product lacks tamper evident breakaway band on cap.Belmora LLC · D-136-2013Class ITerminatedJan 30, 2013Trastuzumab Kit containing 1 vial TrastuzumabPresence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the...Genentech Inc · D-135-2013